|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1New York Presbyterian Hospital Lung Transplant Program, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 2Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 3Department of Statistics, Graduate School of Arts and Sciences, Columbia University, New York, NY 4Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 5Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY 6Authors contributed equally to this paper
sk2097{at}columbia.edu
Abstract
BackgroundThe risk factors for venous thromboembolism following lung transplantation are not well established. We aimed to estimate the incidence of venous thromboembolism and to identify risk factors for venous thromboembolism after lung transplantation.
MethodsWe performed a nested case-control study within the cohort of 121 patients who underwent lung transplantation at our center between August 2001 and July 2005. Controls were matched to cases on days from transplant. Cox proportional hazards models were used to identify risk factors for venous thromboembolism.
ResultsTwenty-four patients had deep vein thromboses and 6 had pulmonary emboli (three had both) (22% of the cohort). In multivariate models, older age (p = 0.03), diabetes mellitus (p = 0.03), and pneumonia (p = 0.02) were associated with a higher rate of venous thromboembolism.
ConclusionsVenous thromboembolism is a frequent complication of lung transplantation. Older age, diabetes, and pneumonia increase the rate of venous thromboembolism. Future studies of intensive venous thromboembolism prophylaxis may be warranted.
Key Words: Lung transplantation Pulmonary embolism Venous thrombosis
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |